This inventor holds 1 USPTO granted patent. Top assignee: Hybridon, Inc.. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Steven M. Nesbitt: Innovator in Ribozyme Technology
Introduction
Steven M. Nesbitt is a notable inventor based in Worcester, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of stabilized ribozyme analogs. His work has implications for various applications, including pharmaceuticals and molecular biology.
Latest Patents
Nesbitt holds a patent for "Stabilized ribozyme analogs." This invention discloses stabilized ribozyme analogs that possess the ability to endonucleolytically cleave a sequence of 3' to 5' linked ribonucleotides. The ribozyme analogs include modifications at specific loop, catalytic core, and flanking region nucleotides, which enhance their resistance to nucleases. Additionally, the patent outlines methods for preparing and utilizing these ribozyme analogs, as well as pharmaceutical formulations and kits that incorporate them.
Career Highlights
Steven M. Nesbitt has been associated with Hybridon, Inc., where he has contributed to innovative research and development in the field of ribozyme technology. His expertise and dedication have positioned him as a key figure in advancing this area of study.
Collaborations
One of his notable collaborators is John Goodchild, with whom he has worked on various projects related to ribozyme research.
Conclusion
Steven M. Nesbitt's contributions to the field of ribozyme technology through his patent and work at Hybridon, Inc. highlight his role as an influential inventor. His innovations continue to pave the way for advancements in biochemistry and pharmaceutical applications.